Literature DB >> 6320667

Viewing the ventromedial hypothalamus from the adrenal gland.

M F Dallman.   

Abstract

The relationships among food intake, insulin secretion, and adrenocortical function are reviewed. It is hypothesized that a major role of structures in, or passing through, the ventromedial hypothalamus is to inhibit food intake, insulin secretion, and adrenocortical function during the day (in the nocturnally active rat) and that this activity is normally driven by elements within the suprachiasmatic nuclei. Lesions of the ventromedial hypothalamus of rats result in nonrhythmic food intake, hyperinsulinemia, nonrhythmic adrenocortical function, and obesity. Adrenalectomy prevents or reverses the effects of lesions of the ventromedial hypothalamus on food intake, insulin secretion, and obesity, and corticosteroid replacement restores them. Because the actions of corticosteroids are both time- and dose-dependent, it is proposed that the effects of the tonic levels of corticosteroids observed after lesions of the ventromedial hypothalamus are to augment the hyperphagia, hyperinsulinemia, and substrate flow into fat to a greater extent than would occur if there were a normal circadian rhythm in adrenocortical function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6320667     DOI: 10.1152/ajpregu.1984.246.1.R1

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Corticotropin releasing factor receptor type II (CRF2) messenger ribonucleic acid levels in the hypothalamic ventromedial nucleus of the infant rat are reduced by maternal deprivation.

Authors:  M Eghbal-Ahmadi; C G Hatalski; S Avishai-Eliner; T Z Baram
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

2.  Ingestion and emotional health.

Authors:  N K Dess
Journal:  Hum Nat       Date:  1991-09

3.  Hypothalamic ventromedial nuclei amplify circadian rhythms: do they contain a food-entrained endogenous oscillator?

Authors:  S Choi; L S Wong; C Yamat; M F Dallman
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

4.  The developmental profile of the corticotropin releasing factor receptor (CRF2) in rat brain predicts distinct age-specific functions.

Authors:  M Eghbal-Ahmadi; C G Hatalski; T W Lovenberg; S Avishai-Eliner; D T Chalmers; T Z Baram
Journal:  Brain Res Dev Brain Res       Date:  1998-04-17

Review 5.  Insulin, corticosterone and the autonomic nervous system in animal obesities: a viewpoint.

Authors:  B Jeanrenaud
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

6.  Serotonin mediated changes in corticotropin releasing factor mRNA expression and feeding behavior isolated to the hypothalamic paraventricular nuclei.

Authors:  Joanne P Boisvert; Tyler J Boschuetz; Jon M Resch; Christopher R Mueller; Sujean Choi
Journal:  Neurosci Lett       Date:  2011-05-11       Impact factor: 3.046

7.  Adrenalectomy reduces neuropeptide Y-induced insulin release and NPY receptor expression in the rat ventromedial hypothalamus.

Authors:  T Wisialowski; R Parker; E Preston; A Sainsbury; E Kraegen; H Herzog; G Cooney
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

8.  Differential regulation of the expression of corticotropin-releasing factor receptor type 2 (CRF2) in hypothalamus and amygdala of the immature rat by sensory input and food intake.

Authors:  M Eghbal-Ahmadi; S Avishai-Eliner; C G Hatalski; T Z Baram
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

9.  Repeated binge access to a palatable food alters feeding behavior, hormone profile, and hindbrain c-Fos responses to a test meal in adult male rats.

Authors:  Nicholas T Bello; Angela S Guarda; Chantelle E Terrillion; Graham W Redgrave; Janelle W Coughlin; Timothy H Moran
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-06-17       Impact factor: 3.619

10.  Melatonin, cortisol and body temperature rhythms in Lennox-Gastaut patients with or without circadian rhythm sleep disorders.

Authors:  M L Laakso; L Leinonen; T Hätönen; A Alila; H Heiskala
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.